{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T20:42:01Z","timestamp":1787431321570,"version":"build-2736575974"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T00:00:00Z","timestamp":1620086400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T00:00:00Z","timestamp":1620086400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program","doi-asserted-by":"crossref","award":["2018YFC1002105"],"award-info":[{"award-number":["2018YFC1002105"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the CAMS Innovation Fund for Medical Sciences","award":["2017-I2m-2-002"],"award-info":[{"award-number":["2017-I2m-2-002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Polycystic ovary syndrome (PCOS) is a multifactorial endocrinopathy that affects reproduction and metabolism. Mammalian target of rapamycin (mTOR) has been shown to participate in female reproduction under physiological and pathological conditions. This study aimed to investigate the role of mTOR complex 1 (mTORC1) signaling in dehydroepiandrosterone (DHEA)-induced PCOS mice.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Female C57BL\/6J mice were randomly assigned into three groups: control group, DHEA group, and DHEA\u2009+\u2009rapamycin group. All DHEA-treated mice were administered 6\u00a0mg\/100\u00a0g DHEA for 21 consecutive days, and the DHEA\u2009+\u2009rapamycin group was intraperitoneally injected with 4\u00a0mg\/kg rapamycin every other day for the last 14 days of the DHEA treatment. There was no obvious change in the expression of mTORC1 signaling in the ovaries of the control and DHEA groups. Rapamycin did not protect against DHEA-induced acyclicity and PCO morphology, but impeded follicle development and elevated serum testosterone levels in DHEA-induced mice, which was related with suppressed <jats:italic>Hsd3b1<\/jats:italic>, <jats:italic>Cyp17a1<\/jats:italic>, and <jats:italic>Cyp19a1<\/jats:italic> expression. Moreover, rapamycin also exacerbated insulin resistance but relieved lipid metabolic disturbance in the short term.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Rapamycin exacerbated reproductive imbalance in DHEA-induced PCOS mice, which characterized by elevated testosterone levels and suppressed steroid synthesis. This underscores the need for new mTORC1-specific and tissue-specific mTOR-related drugs for reproductive disorders.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13048-021-00813-0","type":"journal-article","created":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T19:51:42Z","timestamp":1620157902000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Short\u2010term rapamycin administration elevated testosterone levels and exacerbated reproductive disorder in dehydroepiandrosterone\u2010induced polycystic ovary syndrome mice"],"prefix":"10.1186","volume":"14","author":[{"given":"Zaixin","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penghui","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9737-5957","authenticated-orcid":false,"given":"Qi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,4]]},"reference":[{"issue":"10","key":"813_CR1","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1093\/humrep\/des232","volume":"27","author":"BO Yildiz","year":"2012","unstructured":"Yildiz BO, Bozdag G, Yapici Z, Esinler I, Yarali H. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum Reprod. 2012;27(10):3067\u201373.","journal-title":"Hum Reprod"},{"issue":"5","key":"813_CR2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrendo.2018.24","volume":"14","author":"HF Escobar-Morreale","year":"2018","unstructured":"Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018;14(5):270\u201384.","journal-title":"Nat Rev Endocrinol"},{"key":"813_CR3","doi-asserted-by":"crossref","unstructured":"Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS). Human reproduction (Oxford, England). 2012;27(1):14\u201324.","DOI":"10.1093\/humrep\/der396"},{"issue":"4","key":"813_CR4","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1210\/jc.2004-1045","volume":"90","author":"T Apridonidze","year":"2005","unstructured":"Apridonidze T, Essah PA, Iuorno MJ, Nestler JE. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005;90(4):1929\u201335.","journal-title":"J Clin Endocrinol Metab"},{"key":"813_CR5","first-page":"115","volume":"279","author":"X Long","year":"2004","unstructured":"Long X, Muller F, Avruch J. TOR action in mammalian cells and in Caenorhabditis elegans. Curr Top Microbiol Immunol. 2004;279:115\u201338.","journal-title":"Curr Top Microbiol Immunol"},{"issue":"3","key":"813_CR6","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S1097-2765(02)00636-6","volume":"10","author":"R Loewith","year":"2002","unstructured":"Loewith R, Jacinto E, Wullschleger S, Lorberg A, Crespo JL, Bonenfant D, Oppliger W, Jenoe P, Hall MN. Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. Mol Cell. 2002;10(3):457\u201368.","journal-title":"Mol Cell"},{"key":"813_CR7","doi-asserted-by":"publisher","first-page":"692","DOI":"10.3389\/fendo.2019.00692","volume":"10","author":"Z Guo","year":"2019","unstructured":"Guo Z, Yu Q. Role of mTOR signaling in female reproduction. Front Endocrinol (Lausanne). 2019;10:692.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"813_CR8","doi-asserted-by":"crossref","unstructured":"Guo J, Zhang T, Guo Y, Sun T, Li H, Zhang X, Yin H, Cao G, Yin Y, Wang H, et al. Oocyte stage-specific effects of MTOR determine granulosa cell fate and oocyte quality in mice. Proc Natl Acad Sci. 2018;115(23):5326-33.","DOI":"10.1073\/pnas.1800352115"},{"issue":"10","key":"813_CR9","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1210\/me.2012-1106","volume":"26","author":"M Palaniappan","year":"2012","unstructured":"Palaniappan M, Menon KM. Luteinizing hormone\/human chorionic gonadotropin-mediated activation of mTORC1 signaling is required for androgen synthesis by theca-interstitial cells. Mol Endocrinol. 2012;26(10):1732\u201342.","journal-title":"Mol Endocrinol"},{"issue":"1","key":"813_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1757-2215-2-17","volume":"2","author":"S Fukuda","year":"2009","unstructured":"Fukuda S, Orisaka M, Tajima K, Hattori K, Kotsuji F. Luteinizing hormone-induced Akt phosphorylation and androgen production are modulated by MAP Kinase in bovine theca cells. J Ovarian Res. 2009;2(1):17.","journal-title":"J Ovarian Res"},{"issue":"4","key":"813_CR11","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/s41580-019-0199-y","volume":"21","author":"GY Liu","year":"2020","unstructured":"Liu GY, Sabatini DM. mTOR at the nexus of nutrition, growth, ageing and disease. Nat Rev Mol Cell Biol. 2020;21(4):183\u2013203.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"813_CR12","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1757-2215-5-38","volume":"5","author":"A Yaba","year":"2012","unstructured":"Yaba A, Demir N. The mechanism of mTOR (mammalian target of rapamycin) in a mouse model of polycystic ovary syndrome (PCOS). J Ovarian Res. 2012;5(1):38.","journal-title":"J Ovarian Res"},{"issue":"2","key":"813_CR13","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1159\/000464351","volume":"83","author":"WJ Song","year":"2018","unstructured":"Song WJ, Shi X, Zhang J, Chen L, Fu SX, Ding YL. Akt-mTOR signaling mediates abnormalities in the proliferation and apoptosis of ovarian granulosa cells in patients with polycystic ovary syndrome. Gynecol Obstet Invest. 2018;83(2):124\u201332.","journal-title":"Gynecol Obstet Invest"},{"issue":"9","key":"813_CR14","doi-asserted-by":"publisher","first-page":"867","DOI":"10.3390\/antiox9090867","volume":"9","author":"G Di Emidio","year":"2020","unstructured":"Di Emidio G, Rea F, Placidi M, Rossi G, Cocciolone D, Virmani A, Macchiarelli G, Palmerini MG, D\u2019Alessandro AM, Artini PG, et al. Regulatory functions of L-Carnitine, acetyl, and propionyl L-Carnitine in a PCOS mouse model: focus on antioxidant\/antiglycative molecular pathways in the ovarian microenvironment. Antioxidants. 2020;9(9):867.","journal-title":"Antioxidants"},{"key":"813_CR15","doi-asserted-by":"crossref","unstructured":"McLean AC, Valenzuela N, Fai S, Bennett SA. Performing vaginal lavage, crystal violet staining, and vaginal cytological evaluation for mouse estrous cycle staging identification. J Vis Exp. 2012;(67):e4389.","DOI":"10.3791\/4389"},{"issue":"3","key":"813_CR16","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.cmet.2013.02.008","volume":"17","author":"Y Fang","year":"2013","unstructured":"Fang Y, Westbrook R, Hill C, Boparai RK, Arum O, Spong A, Wang F, Javors MA, Chen J, Sun LY, et al. Duration of rapamycin treatment has differential effects on metabolism in mice. Cell Metab. 2013;17(3):456\u201362.","journal-title":"Cell Metab"},{"key":"813_CR17","doi-asserted-by":"publisher","first-page":"111113","DOI":"10.1016\/j.mce.2020.111113","volume":"521","author":"A Estienne","year":"2021","unstructured":"Estienne A, Bongrani A, Rame C, Kurowska P, Blaszczyk K, Rak A, Ducluzeau PH, Froment P, Dupont J. Energy sensors and reproductive hypothalamo-pituitary ovarian axis (HPO) in female mammals: Role of mTOR (mammalian target of rapamycin), AMPK (AMP-activated protein kinase) and SIRT1 (Sirtuin 1). Mol Cell Endocrinol. 2021;521:111113.","journal-title":"Mol Cell Endocrinol"},{"issue":"11","key":"813_CR18","doi-asserted-by":"publisher","first-page":"5016","DOI":"10.1210\/en.2009-0096","volume":"150","author":"J Roa","year":"2009","unstructured":"Roa J, Garcia-Galiano D, Varela L, S\u00e1nchez-Garrido MA, Pineda R, Castellano JM, Ruiz-Pino F, Romero M, Aguilar E, L\u00f3pez M, et al. The mammalian target of rapamycin as novel central regulator of puberty onset via modulation of hypothalamic kiss1 system. Endocrinology. 2009;150(11):5016\u201326.","journal-title":"Endocrinology"},{"issue":"16","key":"813_CR19","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1242\/jcs.182642","volume":"129","author":"J Guo","year":"2016","unstructured":"Guo J, Shi L, Gong X, Jiang M, Yin Y, Zhang X, Yin H, Li H, Emori C, Sugiura K, et al. Oocyte-dependent activation of MTOR in cumulus cells controls the development and survival of cumulus-oocyte complexes. J Cell Sci. 2016;129(16):3091\u2013103.","journal-title":"J Cell Sci"},{"issue":"8","key":"813_CR20","doi-asserted-by":"publisher","first-page":"e0235404","DOI":"10.1371\/journal.pone.0235404","volume":"15","author":"H Kuang","year":"2020","unstructured":"Kuang H, Duan Y, Li D, Xu Y, Ai W, Li W, Wang Y, Liu S, Li M, Liu X, et al. The role of serum inflammatory cytokines and berberine in the insulin signaling pathway among women with polycystic ovary syndrome. PLoS One. 2020;15(8):e0235404.","journal-title":"PLoS One"},{"issue":"4","key":"813_CR21","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1111\/acel.12617","volume":"16","author":"X Dou","year":"2017","unstructured":"Dou X, Sun Y, Li J, Zhang J, Hao D, Liu W, Wu R, Kong F, Peng X, Li J. Short-term rapamycin treatment increases ovarian lifespan in young and middle-aged female mice. Aging Cell. 2017;16(4):825\u201336.","journal-title":"Aging Cell"},{"key":"813_CR22","doi-asserted-by":"crossref","unstructured":"Yuan X, Hu T, Zhao H, Huang Y, Ye R, Lin J, Zhang C, Zhang H, Wei G, Zhou H, et al. Brown adipose tissue transplantation ameliorates polycystic ovary syndrome. Proc Natl Acad Sci. 2016;113(10):2708-13.","DOI":"10.1073\/pnas.1523236113"},{"issue":"1","key":"813_CR23","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12958-018-0363-9","volume":"16","author":"YL Yang","year":"2018","unstructured":"Yang YL, Sun LF, Yu Y, Xiao TX, Wang BB, Ren PG, Tang HR, Zhang JV. Deficiency of Gpr1 improves steroid hormone abnormality in hyperandrogenized mice. Reprod Biol Endocrinol. 2018;16(1):50.","journal-title":"Reprod Biol Endocrinol"},{"issue":"1","key":"813_CR24","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s12020-016-1065-8","volume":"54","author":"MB Moravek","year":"2016","unstructured":"Moravek MB, Shang M, Menon B, Menon K. HCG-mediated activation of mTORC1 signaling plays a crucial role in steroidogenesis in human granulosa lutein cells. Endocrine. 2016;54(1):217\u201324.","journal-title":"Endocrine"},{"issue":"6","key":"813_CR25","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1210\/er.2011-1034","volume":"33","author":"E Diamanti-Kandarakis","year":"2012","unstructured":"Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012;33(6):981\u20131030.","journal-title":"Endocr Rev"},{"issue":"2","key":"813_CR26","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.cmet.2017.11.004","volume":"27","author":"A Ardestani","year":"2018","unstructured":"Ardestani A, Lupse B, Kido Y, Leibowitz G, Maedler K. mTORC1 Signaling: a double-edged sword in diabetic \u03b2 cells. Cell Metab. 2018;27(2):314\u201331.","journal-title":"Cell Metab"},{"issue":"6","key":"813_CR27","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.molmet.2016.04.001","volume":"5","author":"PL Lee","year":"2016","unstructured":"Lee PL, Tang Y, Li H, Guertin DA. Raptor\/mTORC1 loss in adipocytes causes progressive lipodystrophy and fatty liver disease. Mol Metab. 2016;5(6):422\u201332.","journal-title":"Mol Metab"},{"key":"813_CR28","doi-asserted-by":"crossref","unstructured":"Lerner A, Owens L, Coates M, Simpson C, Poole G, Velupillai J, Liyanage M, Christopoulos G, Lavery S, Hardy K, et al. Expression of genes controlling steroid metabolism and action in granulosa-lutein cells of women with polycystic ovaries. Mol Cell Endocrinol. 2019;486:47-54.","DOI":"10.1016\/j.mce.2019.02.015"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-021-00813-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-021-00813-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-021-00813-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T19:51:55Z","timestamp":1620157915000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-021-00813-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,4]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["813"],"URL":"https:\/\/doi.org\/10.1186\/s13048-021-00813-0","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,4]]},"assertion":[{"value":"25 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures were approved by the Committee on the Ethics of Animal Experiments of Peking Union Medical College Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"64"}}